The GOP senator objected to Secretary Kennedy's recasting of the influential advisory panel, which has sparked criticism from ...

Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely ...

The agency said it will evaluate whether further regulatory action is needed after investigating the deaths of two patients ...

Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...

Jaqueline Corrigan-Curay, who serves as acting head of the FDA’s Center for Drug Evaluation and Research, will depart next ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene ...

Vasomotor symptoms include hot flashes and disrupted sleep, and are typically associated with menopause. However, these symptoms can occur in almost 90% of women with early breast cancer who are ...

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

A dramatic pullback in public biotech investment catalyzed by economic and regulatory upheaval is putting even more stress on ...